Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dialysis Patients Have Higher COVID-19 Mortality Rates

By HospiMedica International staff writers
Posted on 15 Jun 2020
A new study suggests that SARS-CoV-2 infection affects a significant percentage of renal replacement therapy (RRT) patients. More...


A new report by researchers at Hospital Clínic de Barcelona (Spain), Hospital Universitario La Paz (Madrid, Spain), and other members of the Spanish Society of Nephrology (SEN) conducted an analysis of the new SEN online COVID-19 registry, which began operating on March 18th, 2020, and which includes all RRT patients treated in the Spanish autonomous communities. All suspected patients were diagnosed with SARS-CoV-2 infection based on the results of a polymerase chain reaction (PCR) test of the virus.

The most represented form of RRT was in-center hemodialysis (ICH), followed by transplant patients. COVID-19 symptoms among them were similar to the general population. The results showed that a very high percentage (85%) required hospital admission, 8% in intensive care units (ICUs). Mortality was also high, reaching 23%; deceased patients were more frequently on ICH, developed pneumonia more frequently, and received less lopinavir–ritonavir and steroids. Age and pneumonia were independently associated with the risk of death. The study was published on May 1, 2020, in Nefrologia.

“Dialysis patients with SARS-CoV-2 infection have a higher risk of dying than transplant patients, probably related to older age and comorbidity,” concluded lead author J. Emilio Sánchez-Álvarez, MD, of Hospital Universitario de Cabueñes (Gijón, Spain), and colleagues. “Analysis of factors independently associated with the risk of death show that age and the development of pneumonia determine a worse prognosis. Furthermore, in the group of patients on dialysis, the use of hydroxychloroquine is associated with a lower rate of deaths; however, the significance of this last finding requires studies in a larger number of patients.”

Another study, conducted at Hospital Gregorio Marañón (Madrid, Spain) confirmed that the death rate in RRT patients in Spain was as high as 30.5%. The study also analyzed predictors of mortality, finding that in addition to patient older age and pneumonia, three factors significantly influence the mortality rate among coronavirus-positive RRT patients: the number of years on dialysis; lymphopenia, which describes a low number of lymphocytes; and elevated lactate dehydrogenase (LDH) levels, a surrogate for tissue damage.

Related Links:
Hospital Clínic de Barcelona
Hospital Universitario La Paz



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.